Antitumor activity of anaerobic Corynebacterium isolated from the human bone marrow.
D000818:Animals; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001853:Bone Marrow / Q000382:microbiology*; D001854:Bone Marrow Cells; D016026:Bone Marrow Transplantation; D002286:Carcinoma, Ehrlich Tumor / Q000517:prevention & control*; D002473:Cell Wall / Q000276:immunology; D003352:Corynebacterium / Q000166:cytology / Q000276:immunology*; D003355:Corynebacterium pyogenes / Q000276:immunology; D005260:Female; D006801:Humans; D008297:Male; D051379:Mice; D008937:Mitomycins / Q000627:therapeutic use; D009368:Neoplasm Transplantation; D013154:Spleen / Q000637:transplantation; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D008937:Mitomycins